Statistics

Total Visits

Views
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer 11

Total Visits Per Month

November 2022 December 2022 January 2023 February 2023 March 2023 April 2023 May 2023
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer 0 0 0 11 0 0 0

File Visits

Views
Palafox_nc_high.pdf 5

Top country views

Views
United States 9
Spain 2

Top cities views

Views
San Ramon 5
Barcelona 2
Redmond 2
Ann Arbor 1
San Diego 1

Search DSpace


Advanced Search

Browse

My Account

Statistics

Compliant to Partaking